Page 104 - Read Online

Zhang et al. Cancer Drug Resist 2024;7:34 https://dx.doi.org/10.20517/cdr.2024.59 Page 15 of 20

42. Manikandan M, Deva Magendhra Rao AK, Arunkumar G, et al. Oral squamous cell carcinoma: microRNA expression profiling and
integrative analyses for elucidation of tumourigenesis mechanism. Mol Cancer 2016;15:28. DOI PubMed PMC
43. Yang J, Wu SP, Wang WJ, et al. A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC
biology and drug sensitivity in nasopharyngeal cancer. Exp Cell Res 2020;391:111817. DOI PubMed
44. Deng X, Liu Z, Liu X, et al. miR-296-3p negatively regulated by nicotine stimulates cytoplasmic translocation of c-Myc via MK2 to
suppress chemotherapy resistance. Mol Ther 2018;26:1066-81. DOI PubMed PMC
45. Huni KC, Cheung J, Sullivan M, Robison WT, Howard KM, Kingsley K. Chemotherapeutic drug resistance associated with
differential miRNA expression of miR-375 and miR-27 among oral cancer cell lines. Int J Mol Sci 2023;24:1244. DOI PubMed
PMC
46. Shaw P, Raymond G, Senthilnathan R, et al. Clinical theragnostic relationship between chemotherapeutic resistance, and sensitivity
and miRNA expressions in head and neck cancers: a systematic review and meta-analysis protocol. Genes 2021;12:2029. DOI
PubMed PMC
47. Li T, Zhang G, Li W, et al. MicroRNA-101-3p inhibits nasopharyngeal carcinoma cell proliferation and cisplatin resistance through
ZIC5 down-regulation by targeting SOX2. Biol Chem 2023;404:961-75. DOI PubMed
48. Chen L, Xu Z, Zhao J, et al. H19/miR-107/HMGB1 axis sensitizes laryngeal squamous cell carcinoma to cisplatin by suppressing
autophagy in vitro and in vivo. Cell Biol Int 2021;45:674-85. DOI PubMed
49. Sayyed AA, Gondaliya P, Mali M, et al. MiR-155 inhibitor-laden exosomes reverse resistance to cisplatin in a 3D tumor spheroid and
xenograft model of oral cancer. Mol Pharm 2021;18:3010-25. DOI PubMed
50. Yang Y, Sun X, Li M, Li L, Wang S, Zhu Y. miR-214 modulates the growth and migration of oral cancer before and after
chemotherapy through mediating ULK1. J Immunol Res 2022;2022:4589182. DOI PubMed PMC
51. Wenhao R, Yali C, Shaoming L, Jingjing Z, Ling G, Keqian Z. circAP1M2 activates ATG9A-associated autophagy by inhibiting
miR-1249-3p to promote cisplatin resistance in oral squamous cell carcinoma. J Cell Physiol 2023;238:2612-24. DOI PubMed
52. Zhao Y, Wang P, Wu Q. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting
ATG2B. Mol Cell Probes 2020;53:101597. DOI PubMed
53. Fan S, Tian T, Chen W, et al. Mitochondrial miRNA determines chemoresistance by reprogramming metabolism and regulating
mitochondrial transcription. Cancer Res 2019;79:1069-84. DOI PubMed PMC
54. Chen W, Wang P, Lu Y, et al. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming
glucose metabolism and inhibiting MT-CO3 translation. Theranostics 2019;9:5739-54. DOI PubMed PMC
55. Mortezagholi B, Nasiri K, Movahed E, et al. MiR-34 by targeting p53 induces apoptosis and DNA damage in paclitaxel-resistant
human oral squamous carcinoma cells. Chem Biol Drug Des 2023;102:285-91. DOI PubMed
56. Nakashima C, Fujiwara-Tani R, Mori S, et al. An axis between the long non-coding RNA HOXA11-AS and NQOs enhances
metastatic ability in oral squamous cell carcinoma. Int J Mol Sci 2022;23:10704. DOI PubMed PMC
57. Kang SH, Oh SY, Lee KY, et al. Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin
resistance in oral squamous cell carcinoma via miR-876-3p. Theranostics 2024;14:460-79. DOI PubMed PMC
58. Li P, Yang Y, Liu H, et al. MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1. J
Hematol Oncol 2017;10:32. DOI PubMed PMC
59. Luo X, Li Y, Hua Z, et al. Exosomes-mediated tumor metastasis through reshaping tumor microenvironment and distant niche. J
Control Release 2023;353:327-36. DOI PubMed
60. Dai J, Su Y, Zhong S, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther
2020;5:145. DOI PubMed PMC
61. Huang C, Zhou Y, Feng X, Wang J, Li Y, Yao X. Delivery of engineered primary tumor-derived exosomes effectively suppressed the
colorectal cancer chemoresistance and liver metastasis. ACS Nano 2023;17:10313-26. DOI PubMed
62. Qin X, Guo H, Wang X, et al. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and
neck cancer through targeting CDKN1B and ING5. Genome Biol 2019;20:12. DOI PubMed PMC
63. Li J, Hu C, Chao H, et al. Exosomal transfer of miR-106a-5p contributes to cisplatin resistance and tumorigenesis in nasopharyngeal
carcinoma. J Cell Mol Med 2021;25:9183-98. DOI PubMed PMC
64. Babaei G, Aziz SG, Jaghi NZZ. EMT, cancer stem cells and autophagy; The three main axes of metastasis. Biomed Pharmacother
2021;133:110909. DOI PubMed
65. Rao X, Zhang C, Luo H, et al. Targeting gastric cancer stem cells to enhance treatment response. Cells 2022;11:2828. DOI PubMed
PMC
66. Lu H, Ju DD, Yang GD, et al. Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell
proliferation of endometrial carcinoma. EBioMedicine 2019;40:276-89. DOI PubMed PMC
67. Jang TH, Huang WC, Tung SL, et al. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via
the integrin/FAK/Src/ERK/β-catenin pathway. J Biomed Sci 2022;29:42. DOI PubMed PMC
68. Lin SC, Wu HL, Yeh LY, Yang CC, Kao SY, Chang KW. Activation of the miR-371/372/373 miRNA cluster enhances oncogenicity
and drug resistance in oral carcinoma cells. Int J Mol Sci 2020;21:9442. DOI PubMed PMC
69. Cai L, Long Y, Chong T, et al. EBV-miR-BART7-3p imposes stemness in nasopharyngeal carcinoma cells by suppressing SMAD7.
Front Genet 2019;10:939. DOI PubMed PMC
70. Zhang P, Lu X, Shi Z, et al. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling